Biomea Fusion Correlations
BMEA Stock | USD 2.84 0.50 14.97% |
The current 90-days correlation between Biomea Fusion and Werewolf Therapeutics is 0.17 (i.e., Average diversification). The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biomea Fusion Correlation With Market
Very weak diversification
The correlation between Biomea Fusion and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and DJI in the same portfolio, assuming nothing else is changed.
Biomea |
Moving together with Biomea Stock
0.63 | ILMN | Illumina | PairCorr |
0.76 | KURA | Kura Oncology | PairCorr |
0.91 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.91 | ADTX | Aditxt Inc | PairCorr |
0.73 | ANAB | AnaptysBio | PairCorr |
0.93 | STRO | Sutro Biopharma | PairCorr |
0.9 | TCRX | Tscan Therapeutics | PairCorr |
0.73 | TERN | Terns Pharmaceuticals | PairCorr |
0.73 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.63 | CRSP | Crispr Therapeutics | PairCorr |
0.81 | DAWN | Day One Biopharmaceu | PairCorr |
0.65 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Biomea Stock
0.67 | PHGE | Biomx Inc | PairCorr |
0.65 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.6 | GANX | Gain Therapeutics | PairCorr |
0.57 | OPT | Opthea | PairCorr |
0.52 | FENC | Fennec Pharmaceuticals | PairCorr |
0.51 | LTRN | Lantern Pharma | PairCorr |
0.49 | CUE | Cue Biopharma | PairCorr |
0.42 | XFOR | X4 Pharmaceuticals | PairCorr |
0.72 | CGTX | Cognition Therapeutics | PairCorr |
0.47 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.82 | SSNLF | Samsung Electronics | PairCorr |
0.69 | OBI | Ondine Biomedical | PairCorr |
0.53 | EC | Ecopetrol SA ADR | PairCorr |
0.5 | GPI | Group 1 Automotive | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Biomea Stock performing well and Biomea Fusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biomea Fusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EWTX | 2.69 | (0.25) | 0.00 | 0.28 | 0.00 | 4.81 | 26.44 | |||
HOWL | 2.86 | (0.37) | 0.00 | (2.51) | 0.00 | 6.74 | 18.29 | |||
CGEM | 2.46 | (0.62) | 0.00 | (1.52) | 0.00 | 4.98 | 15.27 | |||
DSGN | 4.19 | (0.06) | 0.00 | (0.07) | 0.00 | 8.72 | 26.51 | |||
IKNA | 1.75 | (0.28) | 0.00 | (0.38) | 0.00 | 3.87 | 16.13 |
Biomea Fusion Corporate Management
Juan MD | Chief Officer | Profile | |
Caroline Dupont | Senior Contracts | Profile | |
Naomi Cretcher | Chief Officer | Profile | |
Heow Tan | Chief Officer | Profile | |
Stephan MD | Chief Officer | Profile | |
Franco Valle | CFO Officer | Profile |